In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

J&J buys Inverness diabetes products business

Executive Summary

Johnson & Johnson has acquired the diabetes self-management business of Inverness Medical Technology in a stock swap. Inverness will spin off its lesser lines--women's health, nutritional supplements, plus technology for diagnostics applications outside diabetes--into a separately traded public company to be owned by Inverness shareholders.
Deal Industry
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Glucose Testing
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Stock
    • Full Acquisition
    • Includes Contract

Related Companies

Advertisement
UsernamePublicRestriction

Register